Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT06608693
Eligibility Criteria:
Inclusion Criteria:
* A clinical diagnosis of CP;
* Age ranging from 6 to 18 years;
* No recent administration of Botulinum Toxin to the lower extremity muscles in the last 6 months;
* An IQ score of 70 or above;
* A Gross Motor Function Classification System (GMFCS) value of 1, 2 or 3;
* Presence of hip flexion contracture;
* Willingness to participate in the study
Exclusion Criteria:
* Concomitant diagnoses aside from CP,
* Presenting with muscle tone ratings of 3 or 4 in the hip muscles according to the Modified Ashworth Scale (MAS),
* Who had undergone tendon lengthening surgery to increase hip flexion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
18 Years
Study:
NCT06608693
Study Brief:
Protocol Section:
NCT06608693